Impact of Chronic Kidney Disease on Aortic Dissection in Patients with Polycystic Kidney Disease: A Fifteen-year Nationwide Population-based Cohort Study in Taiwan

被引:0
作者
Fan, Chia-Ning [1 ,2 ]
Chung, Chi-Hsiang [3 ,4 ]
Chien, Wu-Chien [3 ,4 ]
Tsao, Chang-Huei [3 ,5 ]
Weng, Tzu-Hsuan [3 ]
Wu, Kun-Lin [6 ,7 ,8 ]
Chiang, Wen-Fang [6 ,7 ]
Yen, Chih-Chien [1 ,2 ]
Chan, Jenq-Shyong [6 ,7 ]
Hsiao, Po-Jen [6 ,7 ,9 ]
机构
[1] Taoyuan Armed Forces Gen Hosp, Dept Surg, Taoyuan, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan
[3] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan
[4] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan
[5] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan
[6] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Nephrol, Taipei, Taiwan
[7] Taoyuan Armed Forces Gen Hosp, Dept Internal Med, Div Nephrol, 168 Zhongxing Rd, Taoyuan 325, Taiwan
[8] Natl Cent Univ, Inst Syst Biol & Bioinformat, Dept Biomed Sci & Engn, Taoyuan, Taiwan
[9] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan
来源
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2025年 / 22卷 / 07期
关键词
polycystic kidney disease; aortic dissection; chronic kidney disease; end-stage renal disease; hemodialysis; cardiovascular risk; HYPERTENSION; MISDIAGNOSIS; PROGRESSION; INHIBITION; MANAGEMENT; MORTALITY;
D O I
10.7150/ijms.106518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Aortic dissection is a life-threatening condition associated with polycystic kidney disease (PKD). Additionally, PKD often progresses to chronic kidney disease (CKD), a known risk factor for cardiovascular disease. However, the impact of CKD on aortic dissection, particularly in patients with PKD, remains unclear. This study aims to investigate the effects of both CKD and PKD on aortic dissection. Materials and methods: This nationwide, population-based, retrospective cohort study used data from the National Health Insurance Research Database (NHIRD) in Taiwan. The primary outcome evaluated in this study was the cumulative incidence of aortic dissection, compared between PKD patients and a control group without PKD over a 15-year follow-up period. CKD subgroup analyses were performed to further assess the impact of CKD progression on the development of aortic dissection. Results: From 2000 to 2015, this study included 9,192 PKD patients and 36,768 matched controls without PKD from the NHIRD. Our findings demonstrated that PKD patients who developed aortic dissection had a higher incidence of comorbidities, including hypertension and coronary artery disease. Aortic dissection was more prevalent among male patients, individuals over 45 years of age, and those in the lowest insured premium group. PKD patients had a 2.53-fold higher adjusted hazard ratio (HR) for developing aortic dissection compared to the control group (95% CI: 1.74 to 3.66, p < 0.001). Notably, PKD patients with concurrent hypertension had a 7.77-fold increased risk of aortic dissection (95% CI: 4.97 to 12.13, p < 0.001). In CKD subgroup analyses, PKD patients without CKD and those with CKD had adjusted HRs of 1.74 and 3.38, respectively (p < 0.001). Among PKD patients with CKD, those who initiated hemodialysis (HD) and those who did not showed adjusted HRs of 3.95 and 2.74, respectively, for aortic dissection (p < 0.001). Conclusion: These findings indicate that the risk of aortic dissection in PKD patients significantly increases with CKD progression. Additionally, hypertension is an independent risk factor for aortic dissection in PKD patients. Careful management of blood pressure and strategies to prevent CKD progression may reduce the incidence of aortic dissection in this population.
引用
收藏
页码:1493 / 1503
页数:11
相关论文
共 52 条
  • [1] Lovatt S, Wong CW, Schwarz K, Borovac JA, Lo T, Gunning M, Et al., Misdiagnosis of aortic dissection: A systematic review of the literature, Am J Emerg Med, 53, pp. 16-22, (2022)
  • [2] Zhan S, Hong S, Shan-shan L, Chen-ling Y, Lai W, Dong-wei S, Et al., Misdiagnosis of aortic dissection: experience of 361 patients, The Journal of Clinical Hypertension, 14, pp. 256-260, (2012)
  • [3] Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Et al., 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary, Circulation, 121, pp. 1544-1579, (2010)
  • [4] Vilacosta I, Aragoncillo P, Canadas V, Roman JAS, Ferreiros J, Rodriguez E., Acute aortic syndrome: a new look at an old conundrum, Postgraduate Medical Journal, 86, pp. 52-61, (2010)
  • [5] Vilacosta I, San Roman JA, di Bartolomeo R, Eagle K, Estrera AL, Ferrera C, Et al., Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review, J Am Coll Cardiol, 78, pp. 2106-2125, (2021)
  • [6] Kurschat CE, Muller RU, Franke M, Maintz D, Schermer B, Benzing T., An approach to cystic kidney diseases: the clinician's view, Nat Rev Nephrol, 10, pp. 687-699, (2014)
  • [7] Lee LJ-H, Tw K, Chu T-S., Epidemiology of Polycystic Kidney Disease in Taiwan, Formosan J Med, 21, pp. 427-433, (2017)
  • [8] Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE., Polycystic kidney disease, Nature Reviews Disease Primers, 4, (2018)
  • [9] Chuang YW, Yu TM, Huang ST, Sun KT, Lo YC, Fu PK, Et al., Young-Adult Polycystic Kidney Disease is Associated with Major Cardiovascular Complications, Int J Environ Res Public Health, 15, (2018)
  • [10] Hydoub YM, Alnuaimi M, Nour S., Catastrophic extrarenal manifestation of autosomal dominant polycystic kidney disease: lessons learnt, BMJ Case Reports, 12, (2019)